This month the FDA approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) to be used for vaccination against nine types of the Human Papillomavirus (HPV). This new vaccination will be able to help prevent five more types of HPV than the previous vaccination, and will work to prevent 90% of cervical, vaginal, vulvar, and anal cancers. Although not yet available, the medical community is working on the release of the new vaccine for the near future.
HPV has a variety of types, and the vaccination works to prevent the types that most commonly lead to cancer. This new vaccination protects against types 16, 18, 31, 33, 45, 52 and 58. In the previous vaccine, only 16 and 18 were vaccinated against—and with Gardasil 9 an additional 20% of cervical cancers are now covered.